Cypress Capital Group Abb Vie Inc. Transaction History
Cypress Capital Group
- $879 Million
- Q3 2024
A detailed history of Cypress Capital Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Cypress Capital Group holds 113,797 shares of ABBV stock, worth $19.9 Million. This represents 2.56% of its overall portfolio holdings.
Number of Shares
113,797
Previous 113,931
0.12%
Holding current value
$19.9 Million
Previous $19.5 Million
15.0%
% of portfolio
2.56%
Previous 2.36%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
3,855Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.9 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.16 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.78 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $310B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...